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Chennai, India
Background: Signiﬁcant numbers of oral squamous cell car-
cinoma develop from potentially malignant disorders (PMDs).
Candida has been extensively studied in leukoplakia, erythroplakia,
Oral submucous ﬁbrosis and Lichen planus. Candida infection
has been linked with malignant transformation ever since it was
reported to cause candidal oral leukoplakia. The improvement of
epithelial dysplasia following elimination of Candida spp. from
infected tissue is added evidence. Eradication of Candida spp. in
the oral cavity of patients with PMDs may help in preventing PMDs
to malignant transformation. Hence this study was aimed to assay
antifungal susceptibility test on Candida spp isolated from PMDs
Methods & Materials: Forty four (42.30%) Candida albicans and
11 (10.57%) non albicans Candida spp (C.tropicalis, C. rugosa, C.
stellatoides) were isolated from saliva of patients with clinically
diagnosed oral potentially malignant disorders (n=104). The iso-
lates were identiﬁed by phenotypic methods (CHROMagar, germ
tube formation, chlamydospore formation, sugar assimilation &
sugar fermentation tests /KB006 HiCandida Identiﬁcation Kit) and
molecular methods (ITS region ampliﬁcation by PCR –RFLP). Anti-
fungal disk diffusion susceptibility testing was performed on the
isolates as per CLSI guidelines on Mueller-Hinton agar with 2% glu-
cose and0.5g/mlmethyleneblue. C. albicansMTCC3017wasused
as control strain. The isolates were assayed for triazoles (Flucona-
zole and Itraconazole), imidazoles (Ketoconazole and Miconazole)
and polyenes (Nystatin and Amphotericin B).
Results: C.albicans was the predominant isolates. Majority of
C.albicans and non albicans Candida sppwere highly susceptible to
azoles, while all isolates were susceptible to polyenes. Five isolates
(11.36%) of C.albicans and one non albicans Candida spp (9.09%) (C.
rugosa) were resistant to triazoles. Two non albicans Candida spp
and a single isolate of C.albicans were resistant to ketaconazole,
while all isolateswere highly susceptible tomiconazole. In addition
resistant mutants of C.albicans to ketaconazole, Fluconazole and
Itraconazole were observed among 15 samples.
Conclusion: The present study highlights the increased preva-
lence of oral candidal carriage in PMDs and their resistance to
azoles. Prompt diagnosis and antifungal screening may help erad-
ication of oral Candidal carriage in preventing PMDs to malignant
transformation. Azole resistance has to be further determined by
genotypic method and broth dilution assay.
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Detection of invasive fungal infections with
broad range panfungal primers and molecular
beacons in a real time quantitative polymerase
chain reaction
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Background: The increasing incidence of Invasive Fungal Infec-
tion in cases of immunosuppressed patients and organ transplant
recepients requires rapid methods for detection of same. Fungi are
difﬁcult to culture and this effectively delays the administration of
appropriate therapy to the patient. Antigen detection assays have
been promising on this score but shows variable sensitivity and
speciﬁcity. Molecular detection by Real time PCR was carried out
and compared with the clinical criteria for invasive fungal infec-
tions.
Methods & Materials: A total of 72 samples (Blood, BAL, CSF,
Ascitic ﬂuid) from patients suspected to be suffering from inva-
sive fungal disease as per EORTC/MSG clinical criteria. Blood / CSF/
BAL Fluid samples were inoculated in automated culture system
MycoF bottle; Flagged sampleswere sub-cultured onto appropriate
fungal culture media for further identiﬁcation. Serological anti-
gen (Galactomannan, b-D-Glucan and Candida Mannan) detection
assays were done simultaneously. Samples were also processed in
parallel for DNA extraction using commercially available kits.
Real Time Quantitative ampliﬁcation of Fungal DNA was carried
out using published panfungal primers targeting the Inter Tran-
scribed Spacer (ITS) regions of the 18S rDNA region of the fungal
genome and molecular beacons capable of detecting medically rel-
evant fungi.
Results: Invasive Fungal Infection was documented in 72 cases
(8 proven, 29 probable and 35 possible). PCR was positive in 21
cases (6/8 in proven cases; 12/29 in probable cases; 3/35 in possible
cases). PCR was negative in blood samples drawn from 72 healthy
controls. Based on the positive results for proven cases of IFI sensi-
tivity, speciﬁcity, positive predictive value and negative predictive
value of PCR were 75%, 76.6%, 28.6% and 96.1% respectively.
